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382a Tuesday, March 3, 2009Bacteria usemultidrug efflux pumps to extrude toxic substrates through their cell
membranes. The RND transporters of the AcrAB-TolC (E.Coli) and MexAB-
OprM (P.Aeruginosa) systems are able to export structurally and chemically dif-
ferent substrates, being responsible of multidrug resistance. While the energy
conversion takes place in the transmembrane domain of AcrB andMexB, the en-
ergy is transducted towards the periplasmic part and used there to initiate what is
believed to be a three-cyclic peristaltic pumping. Using different computational
methods like adaptive bias force (ABF) and targeted molecular dynamics
(TMD), we have investigated the mechanism of substrate uptake and pumping.
WithABFwe have studied the passage of antibiotics from the periplasmand pro-
tein-lipid interface into the inner pore of the pump, while TMD has been used to
assess the effect of conformational changes on the extrusion of drugs (located
into one of the proposed bind-
ing pockets). Finally, analysis
of water distribution in the
transmembrane region repre-
sents an important step to
identify features of the energy
transduction process. Com-
parison between the active
pumps AcrB and MexB
(which show different resis-
tance patterns despite their
homology) provide insights
into the microscopic details
of their functioning.1963-Plat
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Cystic fibrosis (CF) is themost prevalent genetically inherited lethal disease in the
United States, with an especially high incidence rate among people of European
descent and affects at least one in every 2500-4000 newborns. In 90% of CF pa-
tients, the disease is caused by the deletion of phenylalanine-508 (Phe508) from
the first nucleotide-binding domain (NBD1) of the cystic fibrosis transmembrane
conductance regulator (CFTR), a member of the ATP-binding cassette (ABC)
transporter family. Prior experimental studies suggest that the Phe508 deletion
cause the aberrant folding of NBD1 and the misassembly of various CFTR do-
mains. To gain a fuller understanding of the role of Phe508 in channel function
and of the impact of its deletion, we constructed a 3D structural model of CFTR
using the high-resolution structure of another ABC transporter, Sav1866. The
CFTR model predicts, and we validated experimentally, that Phe508 mediates
an interaction betweenNBD1 and the fourth cytoplasmic loop in the secondmem-
brane-spanning domain (MSD2). This interface explains the observed sensitivity
of CFTR assembly to many disease-associated mutations in CL4 as well as in
NBD1. We also confirmed other intra-domain contacts between the cytoplasmic
and membrane-spanning domains that were predicted by the CFTR model. Fur-
thermore, our electrophysiological measurements and molecular dynamics simu-
lations show that these interfaces regulate channel gating and are highly dynamic.
Aside from advancing understanding of CFTR structure and function, this study
identifies the region of CFTR that should be targeted in treating cystic fibrosis.
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Glutamate transporters tightly control the extracellular concentrationof glutamate
in the brain, ensuring excitatory neurotransmission and cell integrity. These trans-
porters utilize the energy of pre-existing ionic gradients to pump the transmitter
against steep concentration gradients. Active transport is achieved by alternately
exposing the ion and substrate binding sites to the extra- and the intracellular
milieu and the catalytic cycle includes at least three conformational states: out-
ward-facing, occluded and inward-facing. The crystal structures of a prokaryotic
glutamate transporter homologue, GltPh, in complex with an inhibitor and a
substrate showed the transporter in the outward-facing and occluded states, re-
spectively, revealing how substrate and ions reach their binding sites from the ex-
tracellular medium. However, the conformational changes mediating the release
of ligands into the cytoplasm are unknown. To gain insights into this process, we
investigated ligand-dependent conformational transitions of the detergent-solubi-
lized purified GltPh. Cysteine cross-linking experiments show that in the absence
of ligands, helical hairpin 2 (HP2), which serves as an extracellular gate of the
transporter, approaches TM2 bringing together residues that are more than 25 A˚apart in the GltPh structures. The direction of HP2 movement is opposite of
the observed in the outward-facing state, suggesting that the gate remains
closed in the novel state of GltPh. We further probed the substrate-dependent
solvent accessibility changes of key regions of the transporter by determining
the kinetics of the fluorescence increase upon the reaction of fluorescein mal-
eimide with single cysteine mutants. These experiments reveal a striking pat-
tern: cytoplasmic residues become more solvent exposed and extracellular
residues become less solvent-exposed upon substrate dissociation. Our results
suggest that the ligand-free state is an inward-facing state of the catalytic cycle
and demonstrate that the transporter can be conformationally constrained in
this state by cysteine cross-linking.
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Structures of secondary active transporters often reveal the presence of
large structural repeats. In the case of LeuT from theNaþ-dependent neurotrans-
mitter symporter (NSS) family, the two repeats, each composed of five trans-
membrane helices, have inverted topology with respect to the plane of the
membrane. An asymmetry between these two repeats in the extracellular-facing
conformation of LeuT is responsible for the formation of the extracellular
pathway. Structural modelingwas performed in order to exchange the conforma-
tions of the two repeats. This resulted in a ~25 net rotation of a four-helix bundle
around an axis in the plane of themembrane,which remarkably, created a confor-
mation of LeuT in an intracellular-facing state. That is, the substrate binding site
becameexposedon the cytoplasmic side, and closedon the extracellular side. The
model therefore proposes a cytoplasmic pathway for proteins with the LeuT fold.
We show that accessibility of residues in this cytoplasmic pathway is consistent
with a substantial number of biochemical accessibility measurements on single-
cysteine mutants at the cytoplasmic face of the homologous mammalian seroto-
nin transporter (SERT). In addition, the inward-facing structure of the related
sugar transporter vSGLT shows significant similarities (Faham et al, Science
2008). Comparison of the two states of LeuT suggests an alternating-access
mechanism in which a bundle of four transmembrane helices ‘rocks’ within
the structure of the remaining helices. More generally, these results suggest
that topologically-inverted repeats in other secondary active transporters may
provide useful clues in understanding their mechanisms.
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Glutamate transporters (EAATs) are essential in clearing glutamate from the
synapse, allowing precise control over excitatory synaptic function. Much has
been learned in recent years about how these proteins function, however little
is known about how the structural basis of this function; how do protein confor-
mational changes lead to transport activity? A homolog of these proteins, GltPh
from Pyrococcus horikoshii, is functionally similar to the mammalian proteins;
co-transporting substrate and sodium ions whilst having an uncoupled chloride
conductance. Importantly, however it has been crystallized and its structure de-
termined, making it an excellent model for understanding how structure and
function are related in the EAATs. In order for transport to proceed, conforma-
tional changes must occur that allow alternating access of the substrate binding
site to both the internal and external solutions. Using fluorescein maleimide la-
beling and protease accessibility studies on single cysteine mutants of GltPh we
have identified regions of the protein involved in this process. Changes in acces-
sibility are seen in the presence of both aspartate and TBOA, a non-transported
competitive inhibitor. Surprisingly, our accessibility studies implicate hereto-
fore unexpected areas of the GltPh protein in the conformational changes associ-
ated with substrate and inhibitor binding. We are also further investigating
functional aspects of GltPh transport using radioligand flux assays.
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The CLC family of chloride transporting proteins is constituted of chloride
channels and chloride-proton antiporters. Of the transporter subclass CLC_ec1
from E.coli has been characterized extensively structurally and functionally,
